8-K: SS&C Technologies Reports Strong Q1 2025 Results, Revenue Up 5.5%

SS&C Technologies announced a 5.5% increase in Q1 2025 GAAP revenue, reaching $1,513.9 million, and a 35.5% increase in Fully Diluted GAAP Earnings Per Share to $0.84.

Summary

• SS&C Technologies Holdings, Inc. announced its Q1 2025 financial results, showcasing revenue growth and increased profitability.
• GAAP revenue reached $1,513.9 million, a 5.5% increase year-over-year.
• Adjusted revenue also grew by 5.5% to $1,514.8 million.
• Fully Diluted GAAP Earnings Per Share increased by 35.5% to $0.84.
• Adjusted Diluted Earnings Per Share rose by 8.3% to $1.44.
• Net cash from operating activities increased significantly by 50.8% to $272.2 million.
• The company bought back 2.4 million shares for $206.9 million at an average price of $87.21 per share.
• SS&C paid down $155.0 million in debt, reducing the net leverage ratio to 2.74 times consolidated EBITDA.
• GAAP net income attributable to SS&C was $213.0 million, up 35.2%.
• Adjusted consolidated EBITDA attributable to SS&C reached $591.9 million, a 6.3% increase.
• The company provides guidance for Q2 2025 and FY 2025, including adjusted revenue, adjusted net income, and adjusted diluted earnings per share estimates.
• SS&C's first quarter 2025 earnings call will take place at 5:00 p.m. eastern time today, April 24, 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, revenue growth, and increased profitability. The management's comments are optimistic, and the company is actively managing its capital structure. However, some risks and uncertainties are acknowledged.

Positives

• SS&C Technologies reported strong revenue growth in Q1 2025, with both GAAP and adjusted revenue increasing by 5.5%.
• The company demonstrated significant improvement in profitability, with Fully Diluted GAAP Earnings Per Share increasing by 35.5%.
• SS&C generated substantial cash from operating activities, with a 50.8% increase compared to the same period in 2024.
• The company actively manages its capital structure, repurchasing shares and reducing debt.
• SS&C's net leverage ratio is 2.74x, secured net leverage ratio is 1.57x LTM consolidated EBITDA attributable to SS&C of $2,337.2 million.

Negatives

• The document mentions reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K, indicating difficulty in forecasting certain GAAP measures.
• The healthcare business saw a slight decline in organic revenue growth, with a (0.4%) change.

Risks

• The company's performance is subject to risks and uncertainties, including the state of the economy, the financial services industry, and cybersecurity threats.
• SS&C's ability to realize anticipated benefits from its acquisitions is a risk factor.
• The company faces competition and must protect its intellectual property.
• Fluctuations in operating results and risks associated with foreign operations could impact performance.
• The company's substantial indebtedness and the market price of its stock are also risk factors.

Future Outlook

SS&C provides guidance for Q2 2025 and FY 2025, including adjusted revenue between $1,489.0 million and $1,529.0 million for Q2 and between $6,118.0 million and $6,238.0 million for the full year. Adjusted diluted earnings per share are projected to be between $1.35 and $1.41 for Q2 and between $5.68 and $6.00 for the full year.

Management Comments

• SS&C reported adjusted revenues of $1,514.8 million and adjusted consolidated EBITDA of $591.9 million, both of which are first quarter record results, says Bill Stone, Chairman and Chief Executive Officer.
• We are leveraging our investments and expanding our capabilities to meet the needs of our global client base.
• We remain excited about our 2025 growth plans.
• As we begin to embed AI and Quantum technologies in our products and services, we see large scale transformation in both financial services and healthcare.
• SS&C is well positioned to take advantage of these trends.

Industry Context

SS&C's focus on financial services and healthcare software aligns with the increasing demand for technology solutions in these sectors. The company's emphasis on AI and Quantum technologies suggests a forward-looking approach to industry trends.

Comparison to Industry Standards

• Without specific competitor data, it's difficult to provide a direct comparison.
• However, SS&C's revenue growth and profitability metrics can be benchmarked against other software and service providers in the financial and healthcare industries.
• Companies like Fiserv, Jack Henry & Associates, and Envestnet are comparable in terms of providing technology solutions to financial institutions.
• In the healthcare sector, companies like Cerner and Allscripts offer similar software and services.
• SS&C's EBITDA margins and EPS growth can be compared to these peers to assess its relative performance.

Management Changes

Stakeholder Impact

• Shareholders benefit from increased earnings per share and share repurchases.
• Employees may benefit from the company's growth and investments in technology.
• Customers can expect improved products and services as SS&C leverages AI and Quantum technologies.
• Creditors benefit from the company's debt reduction efforts.

Next Steps

• SS&C will hold an earnings call on April 24, 2025, to discuss the Q1 2025 results.
• The company will continue to focus on leveraging investments and expanding capabilities to meet client needs.
• SS&C plans to embed AI and Quantum technologies in its products and services.

Key Dates

Keywords

SS&C Technologies, financial results, Q1 2025, revenue, EBITDA, earnings per share, software, financial services, healthcare, organic growth, debt reduction, share repurchase